Signalling through FOXP3 as an X-linked tumor suppressor

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 11, 2010, Pages 1784-1787

  Katoh, Hiroto ^a   Zheng, Pan ^a   Liu, Yang ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Epithelial cell; FOXP3; Prostate cancer; X linked tumor suppressor gene

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MYC PROTEIN; PROTEIN P21; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR FOXP3; TUMOR SUPPRESSOR PROTEIN;

BREAST CANCER; EPIGENETICS; EPITHELIUM CELL; HUMAN; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENES, TUMOR SUPPRESSOR; GENES, X-LINKED; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 77957260371     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.07.015     Document Type: Short Survey

References (31)

1. Abukhdeir A.M., Park B.H. P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 2008, 10:e19.
2. Bettelli E., Dastrange M., Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 2005, 102:5138-5143.
3. Chang X., Gao J.X., Jiang Q., Wen J., Seifers N., Su L., et al. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med 2005, 202:1141-1151.
4. Chen G.Y., Chen C., Wang L., Chang X., Zheng P., Liu Y. Cutting edge: broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. J Immunol 2008, 180:5163-5166.
5. Ebert L.M., Tan B.S., Browning J., Svobodova S., Russell S.E., Kirkpatrick N., et al. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 2008, 68:3001-3009.
6. Fontenot J.D., Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005, 6:331-337.
7. Hinz S., Pagerols-Raluy L., Oberg H.H., Ammerpohl O., Grussel S., Sipos B., et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 2007, 67:8344-8350.
8. Holmes D., Jiang Q., Zhang L., Su L. Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis. Immunol Res 2008, 41:248-266.
9. Jung D.J., Jin D.H., Hong S.W., Kim J.E., Shin J.S., Kim D., et al. Foxp3 expression in p53-dependent DNA damage responses. J Biol Chem 2010, 285:7995-8002.
10. Krejsgaard T., Gjerdrum L.M., Ralfkiaer E., Lauenborg B., Eriksen K.W., Mathiesen A.M., et al. Malignant Tregs express low molecular splice forms of FOXP3 in Sezary syndrome. Leukemia 2008, 22:2230-2239.
11. Lal G., Bromberg J.S. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009, 114:3727-3735.
12. Lee S.M., Gao B., Fang D. FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1. Blood 2008, 111:3599-3606.
13. Li B., Samanta A., Song X., Iacono K.T., Bembas K., Tao R., et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci USA 2007, 104:4571-4576.
14. Liu R., Wang L., Chen G., Katoh H., Chen C., Liu Y., et al. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Res 2009, 69:2252-2259.
15. Liu Y., Wang Y., Li W., Zheng P., Liu Y. Activating transcription factor 2 and c-Jun-mediated induction of FoxP3 for experimental therapy of mammary tumor in the mouse. Cancer Res 2009, 69:5954-5960.
16. Liu Y., Wang L., Zheng P. X-linked tumor suppressors: perplexing inheritance, a unique therapeutic opportunity. Trends Genet 2010, 26:260-265.
17. Lopes J.E., Torgerson T.R., Schubert L.A., Anover S.D., Ocheltree E.L., Ochs H.D., et al. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol 2006, 177:3133-3142.
18. Merlo A., Casalini P., Carcangiu M.L., Malventano C., Triulzi T., Menard S., et al. FOXP3 expression and overall survival in breast cancer. J Clin Oncol 2009, 27:1746-1752.
19. Nakayama K.I., Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006, 6:369-381.
20. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007, 446:685-689.
21. Pan F., Yu H., Dang E.V., Barbi J., Pan X., Grosso J.F., et al. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 2009, 325:1142-1146.
22. Pelengaris S., Khan M., Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002, 2:764-776.
23. Ruan Q., Kameswaran V., Tone Y., Li L., Liou H.C., Greene M.I., et al. Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 2009, 31:932-940.
24. Spector N.L., Blackwell K.L. Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol 2009, 27:5838-5847.
25. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008, 9:194-202.
26. Wang L., Liu R., Li W., Chen C., Katoh H., Chen G.Y., et al. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell 2009, 16:336-346.
27. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006, 126:375-387.
28. Zhang H.Y., Sun H. Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer. Cancer Lett 2010, 287:91-97.
29. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445:936-940.
30. Zuo T., Liu R., Zhang H., Chang X., Liu Y., Wang L., et al. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest 2007, 117:3765-3773.
31. Zuo T., Wang L., Morrison C., Chang X., Zhang H., Li W., et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 2007, 129:1275-1286.